NPI: 1508924770 · WATERVLIET, MI 49098 · Emergency Medicine Physician · NPI assigned 12/04/2006
Authorized official COX, MATTHEW controls 20+ related entities in our dataset. Read more
| Authorized Official | COX, MATTHEW (CFO) |
| Parent Organization | COREWELL HEALTH |
| NPI Enumeration Date | 12/04/2006 |
Other providers sharing the same authorized official: COX, MATTHEW
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,122 | $326K |
| 2019 | 12,937 | $358K |
| 2020 | 9,250 | $266K |
| 2021 | 13,196 | $352K |
| 2022 | 12,937 | $342K |
| 2023 | 18,393 | $503K |
| 2024 | 13,766 | $405K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 41,367 | 38,540 | $2.44M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30,355 | 28,860 | $74K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8,072 | 7,778 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,459 | 1,442 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,382 | 3,356 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 859 | 852 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 333 | 330 | $1K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 386 | 386 | $619.94 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 391 | 388 | $477.81 |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 135 | 135 | $416.60 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 705 | 685 | $404.35 |
| 81002 | 1,778 | 1,748 | $273.60 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 809 | 789 | $206.86 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 176 | 174 | $168.59 |
| 81025 | 227 | 226 | $128.34 | |
| 90686 | 95 | 94 | $97.35 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 110 | 109 | $81.34 |
| 99215 | Prolong outpt/office vis | 66 | 57 | $81.22 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 223 | 220 | $67.10 |
| 81003 | 549 | 540 | $47.97 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 201 | 198 | $32.70 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 58 | 29 | $26.36 |
| 96127 | 161 | 156 | $23.84 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 28 | 28 | $16.13 |
| G0008 | Administration of influenza virus vaccine | 106 | 105 | $14.00 |
| 99406 | 57 | 52 | $8.12 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 500 | 483 | $0.00 |
| 90715 | 13 | 13 | $0.00 |